Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
deal
Biotech
Astellas, Dyno unearth $15M muscle disorder capsid
Astellas Pharma has reached an agreement to license a Dyno Therapeutics AAV capsid engineered for therapeutic delivery to skeletal muscle.
Will Maddox
Apr 8, 2026 8:00am
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
US biotech finds Relief via reverse merger
Nov 4, 2024 1:05pm
GSK taps Medable for decentralized clinical trials, patient dive
Sep 7, 2022 10:42pm
Prosthetics maker Hanger to go private in $1.2B buyout
Jul 22, 2022 10:37am
Novo Holdings' CRO Altasciences continues deal spree
May 6, 2021 7:15am
